These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17712744)

  • 21. Sepsis and septic shock: selection of empiric antimicrobial therapy.
    Cunha BA
    Crit Care Clin; 2008 Apr; 24(2):313-34, ix. PubMed ID: 18361948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New antibiotics for the management of complicated skin and soft tissue infections: are they any better?
    Nathwani D
    Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S24-9. PubMed ID: 19560672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe pseudomonal infections.
    Mutlu GM; Wunderink RG
    Curr Opin Crit Care; 2006 Oct; 12(5):458-63. PubMed ID: 16943726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The new treatment paradigm and the role of carbapenems.
    Masterton RG
    Int J Antimicrob Agents; 2009 Feb; 33(2):105-110. PubMed ID: 18848436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive?
    Paterson DL; Rice LB
    Clin Infect Dis; 2003 Apr; 36(8):1006-12. PubMed ID: 12684913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection?
    Lipsky BA
    Clin Microbiol Infect; 2007 Apr; 13(4):351-3. PubMed ID: 17359317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational approaches to combating resistance.
    Burke JP
    Int J Clin Pract Suppl; 2002 Mar; (125):29-36; discussion 37-9. PubMed ID: 12014855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two decades of imipenem therapy.
    Rodloff AC; Goldstein EJ; Torres A
    J Antimicrob Chemother; 2006 Nov; 58(5):916-29. PubMed ID: 16997845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The choice of antimicrobial therapy by application of pharmacoeconomic principles in view of the most frequently isolated pathogens at the Clinic for Infectious Diseases of the Clinical Center of Vojvodina].
    Stefan-Mikić S; Sević S; Jovanović N; Cvjetković D; Aleksić-Dordević M
    Med Pregl; 2010; 63 Suppl 1():52-9. PubMed ID: 21438205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing antimicrobial prescribing.
    Isturiz RE
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S19-22. PubMed ID: 21129628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination antimicrobial treatment versus monotherapy: the contribution of meta-analyses.
    Paul M; Leibovici L
    Infect Dis Clin North Am; 2009 Jun; 23(2):277-93. PubMed ID: 19393909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tackling empirical antibiotic therapy for ventilator-associated pneumonia in your ICU: guidance for implementing the guidelines.
    Kuti JL; Shore E; Palter M; Nicolau DP
    Semin Respir Crit Care Med; 2009 Feb; 30(1):102-15. PubMed ID: 19199192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain.
    Tellado JM; Sen SS; Caloto MT; Kumar RN; Nocea G
    Scand J Infect Dis; 2007; 39(11-12):947-55. PubMed ID: 17852889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front.
    Kollef MH
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S3-13. PubMed ID: 18713047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short antibiotic treatment courses or how short is short?
    Rubinstein E
    Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S76-9. PubMed ID: 17826038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing bacterial resistance in surgical patients.
    Evans HL; Sawyer RG
    Surg Clin North Am; 2009 Apr; 89(2):501-19, x. PubMed ID: 19281897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
    Rolston KV
    Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic foot infections and antibiotic therapy.
    Zgonis T; Jolly GP; Buren BJ; Blume P
    Clin Podiatr Med Surg; 2003 Oct; 20(4):655-69. PubMed ID: 14636031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.
    Campion M; Scully G
    J Intensive Care Med; 2018 Dec; 33(12):647-655. PubMed ID: 29534630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.